I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 28% ± 16% | |
| astrocyte | 9 studies | 29% ± 15% | |
| microglial cell | 8 studies | 27% ± 9% | |
| macrophage | 8 studies | 26% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 18% ± 6% | |
| epithelial cell | 7 studies | 29% ± 9% | |
| natural killer cell | 6 studies | 19% ± 3% | |
| oligodendrocyte | 6 studies | 23% ± 6% | |
| epithelial cell of proximal tubule | 5 studies | 18% ± 3% | |
| retinal rod cell | 5 studies | 27% ± 7% | |
| glutamatergic neuron | 5 studies | 47% ± 22% | |
| myeloid cell | 4 studies | 22% ± 4% | |
| retinal cone cell | 4 studies | 30% ± 8% | |
| dendritic cell | 4 studies | 26% ± 8% | |
| ciliated cell | 4 studies | 26% ± 5% | |
| fibroblast | 4 studies | 21% ± 4% | |
| GABAergic neuron | 4 studies | 43% ± 16% | |
| oligodendrocyte precursor cell | 4 studies | 31% ± 10% | |
| endothelial cell of lymphatic vessel | 4 studies | 28% ± 5% | |
| classical monocyte | 3 studies | 22% ± 3% | |
| hematopoietic precursor cell | 3 studies | 18% ± 1% | |
| non-classical monocyte | 3 studies | 19% ± 5% | |
| lymphocyte | 3 studies | 23% ± 2% | |
| type I pneumocyte | 3 studies | 19% ± 1% | |
| type II pneumocyte | 3 studies | 25% ± 3% | |
| basal cell | 3 studies | 29% ± 6% | |
| goblet cell | 3 studies | 25% ± 10% | |
| transit amplifying cell | 3 studies | 28% ± 13% | |
| interneuron | 3 studies | 42% ± 22% |
